FDA
-
-
-
-
-
-
-
Virpax Pharmaceuticals (VRPX) Reports Positive Results in Human Study for its Molecular Envelope Technology
-
-
-
-
-
-
-
Virpax Pharmaceuticals (VRPX) Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alt
-
-
-
-
-
-
-
Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™
-
-
-
-
-
-
-
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
-
-
-
-
-
-
-
Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
-
-
-
-
-
-
-
Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review
-
-
-
-
-
-
-
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
-
322,940 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

